1. Home
  2. TUSK vs ENTX Comparison

TUSK vs ENTX Comparison

Compare TUSK & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mammoth Energy Services Inc.

TUSK

Mammoth Energy Services Inc.

HOLD

Current Price

$3.16

Market Cap

137.3M

Sector

Energy

ML Signal

HOLD

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$2.92

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TUSK
ENTX
Founded
2014
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
137.3M
147.4M
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
TUSK
ENTX
Price
$3.16
$2.92
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
102.0K
358.0K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
102.32
N/A
EPS
0.09
0.22
Revenue
$44,292,000.00
$42,000.00
Revenue This Year
$383.90
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$35.78
$13.77
Revenue Growth
N/A
N/A
52 Week Low
$1.72
$0.91
52 Week High
$3.92
$4.20

Technical Indicators

Market Signals
Indicator
TUSK
ENTX
Relative Strength Index (RSI) 54.05 50.47
Support Level $2.98 $2.73
Resistance Level $3.32 $3.10
Average True Range (ATR) 0.12 0.19
MACD -0.01 -0.03
Stochastic Oscillator 65.67 48.94

Price Performance

Historical Comparison
TUSK
ENTX

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes rental services, infrastructure services, natural sand proppant services, accommodation services, and drilling services.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: